- Peak Oil Closer Than IEA Forecasts Show: Report
- UK Most at Risk of Losing Top Credit Rating: Fitch
- GM CEO Starts Charm Tour at Opel in Germany
- Vodafone Extends Cost-Cutting Scheme, Hits Targets
- Bad Debt Weighs on Barclays Earnings
- HSBC Operating Profit Beats, US Bad Debts Slip
- Fed's Tarullo Backs Surcharges to Limit Bank Size
- Look Ahead: 'Risk On' Sentiment Could Fuel Rally Further
- European Commission Objects to Sun Micro-Oracle Deal
- Why Google is Paying $750 Million for Ad Mob
- Warren Buffett to Sell Stakes In Union Pacific & Norfolk Southern
- Nov. 9: Unusual Volume Leaders
- The Battered Businesses Behind Housing
- Modern Warfare 2's Record-Breaking Launch
- Merck’s Mega-Monday Morning
- Why are Traders Bullish on This Food Company?
- Profiting From Natural Gas: Strategists
- S&P Stocks Trading at New 52-Week Highs
MOST SHARED
- Obama Sees Strains Unless US, China Balance Growth
- Can Apple Top Microsoft as Most Valuable Tech Firm?
- Priceline Crushes Profit Forecasts; Shares Jump
- European Commission Objects to Sun Micro-Oracle Deal
- Mad Mail: Buy the Berkshire Hathaway Split?
- Future of Marketing
- Framed for Porn – By a PC Virus
- GM CEO Starts Opel Charm Tour in Germany
- Cramer: 5 Stocks to Play the Next Bull Run
Text Size 
CVS Caremark agreed to acquire its rival Longs Drugs Stores for a total purchase price of $2.9 billion, including debt, and shares of Longs soared [LDG
Loading...
()
] almost 30 percent to $70 in extended trade.
 |
AP |
The deal was expected to crimp earnings per share at CVS Caremark in its first year, but add to earnings beginning in 2010, the companies said.
CVS Caremark is expected to gain cost savings of approximately $100 million in 2009 and approximately $140 million to $150 million in 2010 from purchasing savings and lower selling, general and administrative costs.
"This transaction provides tremendous benefits to CVS Caremark by accelerating our expansion in very attractive drugstore markets and strengthening our geographic reach," the company's chairman and chief executive, Thomas Ryan, said in a statement.
CVS shares [CVS
Loading...
()
] were about 4 percent lower in late trading. Shares of both pharmacy chains were briefly halted earlier.
Print
Email
- Do free market libertarians really believe what they say about ethics and shareholder value? The Big Money takes a look.
- Cramer did the research and found eight stocks that lead the pack. Read on to get his top picks.
- On the anniversary of the fall of the Berlin Wall, many in the former Eastern Bloc recall communism fondly.
- Software, biotech firms, even banks are watching a particular Supreme Court argument today.
- From politicians to CEOs to companies, here's your chance to vote for the winners and losers of 2009.
- The health care reform bill that passed the House on Saturday will have a much harder time in the Senate.
Data is a real-time snapshot *Data is delayed at least 15 minutes